Articles Tagged with Litigation

Recent reports indicate that in addition to problems such as cleft palates and cleft lip from taking Topamax, Topamax may cause oral contraceptives to loose their effectiveness.

Topamax (topiramate) is a popular migraine and seizure medication that has been recently revised by the FDA as a “Class D” pregnancy drug – i.e. one where significant evidence exists that the drug may cause harm to a fetus during pregnancy. Now, combined with evidence that Topamax may render certain birth control ineffective, physicians are urged to inform patients of the danger of Topamax and oral contraceptive interactions.

In addition to the potential for birth defects, patients taking Topamax have developed eye disorders such as glaucoma and acute myopia.
Continue reading

Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that the Zimmer NexGen knee has significant problems and warned against its use.

If you have undergone knee replacement surgery, contact a Zimmer NexGen Knee attorney for more information regarding the Zimmer NexGen knees and its safety risks.
Continue reading

Medical Malpractice reform has been receiving much attention recently with the introduction of H.R. 5, which seeks to impose national tort reforms measures, including the imposition of caps on non-economic damages as well as potentially taking away the right to trial by jury in some medical malpractice cases.

As New Mexico medical malpractice lawyers, we believe such measures often fail to address the real issue – patients safety. Study after study show that patients suffer significant harm and costs in hospitals due to adverse reactions from dangerous drugs, infections, surgical errors and unnecessary procedures. Rather than limiting victims’ access to justice, more focus must be placed on improving patient safety and ensuring that those responsible for causing harm be held accountable.

Recent examples include the DePuy Hip, now shown to leak dangerous chemicals into the bodies of recipients. Often, the only way to get companies to remove dangerous products from the marketplace and be compensated for the harm caused is through litigation. Capping our damages or limiting access to the court room will remove an important incentive to improving the safety of our health care.
Continue reading